Apixaban Tablet 2.5 mg, 5 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2.5 mg, 5 mg
Reference Brands: Eliquis(US /EU/ India)
Category: Blood Disorder
Apixaban inhibits factor Xa, reducing thrombin generation and preventing blood clots. It effectively lowers the risk of stroke, deep vein thrombosis, and pulmonary embolism. Benefits include oral administration, predictable effects, no routine monitoring needed, rapid onset, and reduced bleeding risk, making it a preferred anticoagulant for various thromboembolic conditions.
Product Description:
Apixaban is approved by regulatory authorities in both the EU and US for various indications, including stroke prevention in atrial fibrillation and treatment of DVT/PE. In the US, it is approved by the FDA, requiring a comprehensive dossier demonstrating safety, efficacy, and manufacturing quality. In the EU, approval is granted through the EMA’s centralized procedure, adhering to strict biosimilar and medicinal product standards. Accurate dossier preparation, including pharmacovigilance plans, stability data, and clinical trial evidence, is essential for market authorization. For expert guidance on regulatory strategy, dossier development, and market entry, visit PharmaTradz. Ensuring compliance facilitates smooth approval processes and successful commercialization worldwide.
Apixaban Tablet — third party manufacturing & bulk supply
Apixaban Tablet 2.5 mg, 5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Apixaban Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Apixaban Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Apixaban is used to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Apixaban is a direct factor Xa inhibitor that works by selectively blocking factor Xa in the coagulation cascade, which reduces thrombin formation and prevents blood clot development.
The primary trade name is Eliquis, along with various generic brands available worldwide.
Apixaban is manufactured by Bristol-Myers Squibb in collaboration with Pfizer and is also produced by multiple pharmaceutical companies globally as a generic medicine.
The generic name is Apixaban.
Brand names include Eliquis and other regional generics.
Apixaban is manufactured in the USA, Europe, India, and other regions by multiple pharmaceutical companies under approved regulatory standards.
Related Products
Anagrelide Hydrochloride
Strength:
0.5 mg
Form: Capsules
Reference Brands: Agrylin (USA)
View Details
Ferric Maltol
Strength:
30 mg
Form: Capsules
Reference Brands: Accrufer (USA), Feraccru (EU)
View Details
Lusutrombopag
Strength:
3 mg
Form: Tablets
Reference Brands: Mulpleta (USA), Mulpleo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
